These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31452347)

  • 1. Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report.
    Li S; Sun Y; Shao C; Xu K; Huang H
    Thorac Cancer; 2019 Oct; 10(10):2035-2039. PubMed ID: 31452347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
    Sun Y; Shao C; Xu K; Li J; Zhang Y; Liu P; Huang H; Feng R
    Thorac Cancer; 2020 Jul; 11(7):2040-2043. PubMed ID: 32374517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma of the lung in a patient with nonspecific interstitial pneumonia.
    Gorospe Sarasúa L; Arrieta P; Chinea-Rodríguez A; de la Puente-Bujidos C
    Reumatol Clin (Engl Ed); 2019; 15(6):e151-e152. PubMed ID: 28867466
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological improvement in salivary gland along with effector memory Th17-1 cell reduction in a primary Sjogren's syndrome patient with dermatomyositis and diffuse large B-cell lymphoma by R-CHOP therapy.
    Koga T; Mizokami A; Nakashima M; Shimizu T; Nakashima Y; Nakamura H; Chiwata M; Daisuke N; Kawakami A
    Clin Immunol; 2016 Apr; 165():35-7. PubMed ID: 26960952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P
    J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
    Yousif P; Kotecha A; Thakur A; Ismail HM
    Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
    Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
    J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-induced interstitial lung disease.
    Wagner SA; Mehta AC; Laber DA
    Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
    BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary diffuse large B-cell lymphoma with multiple ground-glass nodules as the primary manifestation: A case report.
    Wang Q; Yan H; Wang R; Li C; Li W; Xu Y; Su Z; Zhang J
    Medicine (Baltimore); 2020 Dec; 99(50):e23501. PubMed ID: 33327289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
    Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
    Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of
    Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
    J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
    Kilani Y; Sohail H; Lim CY; Payette A; Kamal SAF; Afzal A; Khan T; Paracha N; Muppidi MR; Sittler D
    Am J Case Rep; 2022 Sep; 23():e937500. PubMed ID: 36151707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
    Alqatari S; Riddell P; Harney S; Henry M; Murphy G
    BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
    Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
    Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
    Hertzberg M; Gandhi MK; Trotman J; Butcher B; Taper J; Johnston A; Gill D; Ho SJ; Cull G; Fay K; Chong G; Grigg A; Lewis ID; Milliken S; Renwick W; Hahn U; Filshie R; Kannourakis G; Watson AM; Warburton P; Wirth A; Seymour JF; Hofman MS; Hicks RJ;
    Haematologica; 2017 Feb; 102(2):356-363. PubMed ID: 28143954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.